Key Takeaways from Bioceres Crop Solutions Corp (BIOX)’s Recent Sales and Margin Figures

Ulysses Smith

At the time of writing, Bioceres Crop Solutions Corp [BIOX] stock is trading at $1.41, down -1.40%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BIOX shares have gain 2.17% over the last week, with a monthly amount drifted -30.88%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Bioceres Crop Solutions Corp [NASDAQ: BIOX] stock has seen the most recent analyst activity on September 10, 2025, when Canaccord Genuity downgraded its rating to a Hold but kept the price target unchanged to $2.50 for it. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $15 on April 06, 2023. Canaccord Genuity initiated its recommendation with a Buy and recommended $22.50 as its price target on September 30, 2022. ROTH Capital started tracking with a Buy rating for this stock on October 08, 2021, and assigned it a price target of $21. In a note dated March 15, 2021, Lake Street initiated an Buy rating and provided a target price of $15 on this stock.

For the past year, the stock price of Bioceres Crop Solutions Corp fluctuated between $1.20 and $7.80. Currently, Wall Street analysts expect the stock to reach $4.17 within the next 12 months. Bioceres Crop Solutions Corp [NASDAQ: BIOX] shares were valued at $1.41 at the most recent close of the market. An investor can expect a potential return of 195.74% based on the average BIOX price forecast.

Analyzing the BIOX fundamentals

According to Bioceres Crop Solutions Corp [NASDAQ:BIOX], the company’s sales were 333.38M for trailing twelve months, which represents an -40.15% plunge. Gross Profit Margin for this corporation currently stands at 0.39% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.16%, and Net Profit Margin reading is -0.15%. To continue investigating profitability, this company’s Return on Assets is posted at -0.06, Equity is -0.16 and Total Capital is -0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.89.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.

Ratios To Look Out For

It is important to note that Bioceres Crop Solutions Corp [NASDAQ:BIOX] has a current ratio of 1.02. In addition, the Quick Ratio stands at 0.72 and the Cash Ratio stands at 0.12. Considering the valuation of this stock, the price to sales ratio is 0.27, the price to book ratio is 0.28.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.